BCL2L1 and neoplasm: In addition, Bcl‐xL‐expressing tumor cells are significantly less sensitive to mitochondria‐dependent apoptosis induced by chemotherapeutic agents such as paclitaxel [26] and cisplatin, which is an important mechanism for clinical failure.